CDK1 Polyclonal Antibody

CDK1 Polyclonal Antibody

The CDK1 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of cyclin-dependent kinase 1 (CDK1) protein expression. This antibody is produced using a polyclonal approach, ensuring a diverse range of epitope recognition and enhanced sensitivity for accurate results.

CDK1 is a crucial regulator of the cell cycle, playing a pivotal role in the transition from G2 phase to mitosis. Its aberrant expression or dysregulation has been implicated in various pathological conditions, including cancer. Therefore, the CDK1 Polyclonal Antibody serves as an indispensable tool for researchers and clinicians alike, enabling the investigation of CDK1 expression patterns and its potential implications in disease progression.

The CDK1 Polyclonal Antibody exhibits exceptional specificity, exhibiting minimal cross-reactivity with other CDK family members. This specificity ensures reliable and precise detection of CDK1 protein levels in various sample types, including cell lysates, tissue extracts, and immunohistochemistry applications.

Furthermore, this antibody demonstrates excellent sensitivity, allowing for the detection of low-abundance CDK1 protein levels. This attribute is particularly advantageous when working with limited sample quantities or when studying subtle changes in CDK1 expression.

The CDK1 Polyclonal Antibody is manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure consistent performance and reproducibility. It is supplied in a convenient format, ready for immediate use in various experimental settings.

In summary, the CDK1 Polyclonal Antibody is a highly reliable and specific tool for the detection and analysis of CDK1 protein expression. Its exceptional sensitivity and specificity make it an invaluable asset for researchers and clinicians investigating the role of CDK1 in various biological processes and disease states.